DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chlebowski RT, Brzechwa-Adjukiewicz A, Cowden A, Block JB, Tong M, Chan KK.
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results.
Cancer Treat Rep 1984;
68 (3) 487-491
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.